Helsinki University Hospital, Comprehensive Cancer Center, and University of Helsinki, Faculty of Medicine, Helsinki, Finland.
University of Helsinki, Department of Public Health, Helsinki, Finland.
Breast. 2021 Oct;59:110-116. doi: 10.1016/j.breast.2021.06.012. Epub 2021 Jun 26.
To investigate long-term health-related quality of life (HRQoL) changes over time in younger compared to older disease-free breast cancer survivors who participated in a prospective randomized exercise trial.
Survivors (aged 35-68 years) were randomized to a 12-month exercise trial after adjuvant treatment and followed up for ten years. HRQoL was assessed with the generic 15D instrument during follow-up and the younger (baseline age ≤ 50) and older (age >50) survivors' HRQoL was compared to that of the age-matched general female population (n = 892). The analysis included 342 survivors.
The decline of HRQoL compared to the population was steeper and recovery slower in the younger survivors (p for interaction < 0.001). The impairment was also larger among the younger survivors (p = 0.027) whose mean HRQoL deteriorated for three years after treatment and started to slowly improve thereafter but still remained below the population level after ten years (difference -0.017, 95% CI: -0.031 to -0.004). The older survivors' mean HRQoL gradually approached the population level during the first five years but also remained below it at ten years (difference -0.019, 95% CI: -0.031 to -0.007). The largest differences were on the dimensions of sleeping and sexual activity, on which both age groups remained below the population level throughout the follow-up.
HRQoL developed differently in younger and older survivors both regarding the most affected dimensions of HRQoL and the timing of the changes during follow-up. HRQoL of both age groups remained below the population level even ten years after treatment.
调查参加前瞻性随机运动试验的年轻无病乳腺癌幸存者与老年幸存者相比,随时间推移健康相关生活质量(HRQoL)的长期变化。
在辅助治疗后,幸存者(年龄 35-68 岁)被随机分配到为期 12 个月的运动试验中,并在 10 年内进行随访。在随访期间使用通用 15D 工具评估 HRQoL,并将年轻(基线年龄≤50 岁)和老年(年龄>50 岁)幸存者的 HRQoL 与年龄匹配的一般女性人群(n=892)进行比较。该分析包括 342 名幸存者。
与人群相比,年轻幸存者的 HRQoL 下降更快,恢复更慢(交互作用 p<0.001)。年轻幸存者的损害也更大(p=0.027),他们的 HRQoL 在治疗后三年内恶化,此后开始缓慢改善,但 10 年后仍低于人群水平(差异-0.017,95%CI:-0.031 至-0.004)。老年幸存者的平均 HRQoL 在最初五年内逐渐接近人群水平,但 10 年后仍低于人群水平(差异-0.019,95%CI:-0.031 至-0.007)。最大的差异出现在睡眠和性活动维度,两个年龄组在整个随访过程中均低于人群水平。
年轻和老年幸存者的 HRQoL 发展方式不同,包括 HRQoL 受影响最严重的维度以及随访期间变化的时间。两个年龄组的 HRQoL 在治疗后 10 年内仍低于人群水平。